Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Concejo B | CNCJOB | 3. jan 2025 | 44.60 | -0.22 |
Condo Nordic Holding AB | CONDO | 3. jan 2025 | 1.02 | -2.86 |
Consensus B | CAMB | 3. jan 2025 | 9.70 | +0.62 |
Coor Service Management Holding | COOR | 3. jan 2025 | 35.80 | +0.28 |
Corem Property Group A | COREA | 3. jan 2025 | 6.68 | +0.91 |
Corem Property Group B | COREB | 3. jan 2025 | 6.61 | -3.08 |
Corem Property Group D | CORED | 3. jan 2025 | 245.00 | +0.20 |
Corem Property Group Pref | COREPREF | 3. jan 2025 | 264.00 | +0.76 |
Corline Biomedical | CLBIO | 3. jan 2025 | 9.84 | +2.93 |
Cortus Energy | CE | 3. jan 2025 | 0.16 | +1.91 |
Creades A | CREDA | 3. jan 2025 | 73.60 | -1.08 |
Creturner Group | CRET | 3. jan 2025 | 0.27 | -4.30 |
Crown Energy | CRWN | 3. jan 2025 | 0.54 | 0.00 |
Crunchfish | CFISH | 3. jan 2025 | 1.18 | +2.78 |
CTEK | CTEK | 3. jan 2025 | 14.34 | -2.32 |
CTT Systems | CTT | 3. jan 2025 | 277.00 | -2.12 |
Curasight | CURAS | 3. jan 2025 | 9.96 | +12.16 |
Cyber Security 1 | CYB1 | 3. jan 2025 | 0.01 | -2.17 |
Cyclezyme AB | CYCLE | 3. jan 2025 | 6.60 | 0.00 |
Dala Energi | DE | 3. jan 2025 | 100.50 | -0.99 |
Dedicare B | DEDI | 3. jan 2025 | 60.90 | +3.22 |
Desenio | DSNO | 3. jan 2025 | 0.40 | +25.00 |
DevPort | DEVPB | 3. jan 2025 | 28.00 | -0.36 |
Devyser Diagnostics | DVYSR | 3. jan 2025 | 119.00 | -1.24 |
DexTech Medical | DEX | 3. jan 2025 | 3.90 | 0.00 |
Diadrom Holding | DIAH | 3. jan 2025 | 7.20 | +2.56 |
Diagonal Bio | DIABIO | 3. jan 2025 | 0.02 | -3.33 |
Diamyd Medical B | DMYDB | 3. jan 2025 | 18.00 | +5.51 |
Dicot Pharma AB | DICOT | 3. jan 2025 | 0.29 | +8.61 |
Dignitana | DIGN | 3. jan 2025 | 1.17 | -0.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.